Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-15
    E.g., 2018-10-15

Archive Search

2 results
3:11 PM, Jun 01, 2018  |  BioCentury | Emerging Company Profile

Scratching the surface

its platform to develop molecules with bactericidal activity against Gram-negative bacteria. At least two companies, A2A Pharmaceuticals LLC
199,851) Investors: Undisclosed angel investors CEO: Ajay Mistry Patents: None issued Companies and Institutions Mentioned  A2A Pharmaceuticals LLC
12:00 AM, Aug 22, 2016  |  BioCentury | Emerging Company Profile

Metal smithing

hours in a mouse model of wild-type E. coli infection. At least one other company, A2A Pharmaceuticals LLC
its own IP covering the LpxC program and its cancer programs. Companies and Institutions Mentioned A2A Pharmaceuticals LLC